Novel Therapies Targeting Kidney Disease


Latest Press Releases
Press releases
  • 05 Oct 2025  ·  Regulatory information

    Guard Therapeutics Announces New Positive Efficacy Results from Secondary Analyses of the Phase 2a AKITA Study

    Read more
  • 11 Sep 2025

    Guard Therapeutics announces completion of data collection in Phase 2b POINTER study

    Read more
  • 28 Aug 2025

    Guard Therapeutics presents additional AKITA results at leading U.S. nephrology conference

    Read more
  • 22 Aug 2025

    Guard Therapeutics to present at upcoming investor conferences

    Read more
Show more
In focus
  • 16 Sep 2025 / Presentation

    CEO Tobias Agervald appears on BiotechTV

    Read more
  • 17 Oct 2024 / Presentation

    Guard presents at Redeye Theme "Cardiovascular & Metabolic Diseases Event 2024"

    Read more
  • 23 Sep 2024 / Presentation

    CEO Tobias Agervald appears on BiotechTV

    Read more
  • 19 Sep 2024 / Presentation

    Presentation at Pareto Securities' 15th Annual Healthcare Conference

    Read more
Show more
Upcoming events
  • 09 Oct 2025

    Guard presents at Redeye Investor Forum - Gothenburg October 9th

  • 03 Nov 2025

    Guard attends Bio-Europe, Vienna, November 3–5

  • 07 Nov 2025

    Guard presents at ASN Kidney Week in Houston, TX, US on November 5–9

  • 13 Nov 2025

    Interim report January-September 2025

    Read more
Event calendar/Financial calendar